Allergan's Profit Gets Botox Enhancement
Allergan (AGN) reported better-than-expected first-quarter earnings Friday on strong sales of its Botox anti-wrinkle drug and medical devices. It slightly raised the low end of its 2010 profit forecast despite costs of U.S. health care reforms. It said it earned $168 million, or 55 cents per share compared with $45 million, or 15 cents, a year ago, when the company took restructuring charges. Excluding special items, Allergan earned 65 cents per
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here